Sr-144528

Sr-144528

SCHEMBL19551517

Cc1ccc(Cn2nc(C(=O)N[C@H]3C4(C)CC[C@H](C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 18/20 1.00
▸ CNR1 P21554 6/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sr-144528 SCHEMBL1546003 1.00 CNR2 (1.00) CNR2CNR1
Sr-144528 SCHEMBL14355050 1.00 CNR2 (1.00) CNR2CNR1
Sr-144528 SCHEMBL8137029 1.00 CNR2 (1.00) CNR2CNR1
Sr-144528 SCHEMBL8039660 1.00 CNR2 (1.00) CNR2CNR1
Sr-144528 SCHEMBL8313006 1.00 CNR2 (1.00) CNR2CNR1
Sr-144528 SCHEMBL1432281 1.00 CNR2 (1.00) CNR2CNR1
SCHEMBL13883212 0.94 CNR2 (0.88) CNR2CNR1
SCHEMBL13926164 0.94 CNR2 (0.88) CNR2CNR1
SCHEMBL15377558 0.92 CNR2 (0.85) CNR2CNR1
SCHEMBL8042546 0.92 CNR2 (0.85) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452036-A1 USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND RELATED CONNECTIVE TISSUE DISORDERS Inmed Pharmaceuticals Inc. (CA) 2019-03-13 — — EP claimed
WO-2017190249-A1 USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND RELATED CONNECTIVE TISSUE DISORDERS INMED PHARMACEUTICALS INC. (CA) 2017-11-09 — — WO claimed
Send feedback